Clinical Trial Update: Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study [Phase 2]

View source ↗

Summary

Open-phase 2 multicenter trial evaluating Milaberon in advanced solid tumors across multiple indications, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Diffuse Large B-cell Lymphoma
• Non-small Cell Lung Cancer
• Pancreatic Cancer
• Small Cell Lung Cancer
• Squamous Cell Carcinoma of the Head and Neck
• Triple-negative Breast Cancer

Drugs mentioned

• Milaberon (milaberon)

Snippet

Sponsor: Zhejiang Provincial People's Hospital | Conditions: NSCLC, SCLC | Phase 2 | Status: RECRUITING